FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992514303> ?p ?o ?g. }

• W1992514303 endingPage "117" @default.
• W1992514303 startingPage "107" @default.
• W1992514303 abstract "The complex syndrome of cancer cachexia (CC) that occurs in 50% to 80% cancer patients has been identified as an independent predictor of shorter survival and increased risk of treatment failure and toxicity, contributing to the mortality and morbidity in this population. CC is a pathological state including a symptom cluster of loss of muscle (skeletal and visceral) and fat, manifested in the cardinal feature of emaciation, weakness affecting functional status, impaired immune system, and metabolic dysfunction. The most prominent feature of CC is its non-responsiveness to traditional treatment approaches; randomized clinical trials with appetite stimulants, 5-HT3 antagonists, nutrient supplementation, and Cox-2 inhibitors all have failed to demonstrate success in reversing the metabolic abnormalities seen in CC. Interventions based on a clear understanding of the mechanism of CC, using validated markers relevant to the underlying metabolic abnormalities implicated in CC are much needed. Although the etiopathogenesis of CC is poorly understood, studies have proposed that NFkB is upregulated in CC, modulating immune and inflammatory responses induce the cellular breakdown of muscle, resulting in sarcopenia. Several recent laboratory studies have shown that n-3 fatty acid may attenuate protein degradation, potentially by preventing NFkB accumulation in the nucleus, preventing the degradation of muscle proteins. However, clinical trials to date have produced mixed results potentially attributed to timing of interventions (end stage) and utilizing outcome markers such as weight which is confounded by hydration, cytotoxic therapies, and serum cytokines. We propose that selective targeting of proteasome activity with a standardized dose of omega-3-acid ethyl esters, administered to cancer patients diagnosed with early stage CC, in addition to a standard intervention with nutritionally adequate diet and appetite stimulants, will alter metabolic abnormalities by downregulating NFkB, preventing the breakdown of myofibrillar proteins and resulting in increasing serum protein markers, lean body mass, and functional status." @default.
• W1992514303 created "2016-06-24" @default.
• W1992514303 creator A5000121125 @default.
• W1992514303 creator A5001557696 @default.
• W1992514303 creator A5003889511 @default.
• W1992514303 creator A5006390169 @default.
• W1992514303 creator A5007634841 @default.
• W1992514303 creator A5014513676 @default.
• W1992514303 creator A5020085664 @default.
• W1992514303 creator A5027819464 @default.
• W1992514303 creator A5039202604 @default.
• W1992514303 creator A5072289832 @default.
• W1992514303 creator A5090472542 @default.
• W1992514303 creator A5042005001 @default.
• W1992514303 date "2010-12-01" @default.
• W1992514303 modified "2023-10-08" @default.
• W1992514303 title "Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment" @default.
• W1992514303 cites W2003064100 @default.
• W1992514303 cites W2009391027 @default.
• W1992514303 cites W2030342430 @default.
• W1992514303 cites W2052121973 @default.
• W1992514303 cites W4214696474 @default.
• W1992514303 doi "https://doi.org/10.1007/s11864-010-0127-z" @default.
• W1992514303 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3016925" @default.
• W1992514303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21128029" @default.
• W1992514303 hasPublicationYear "2010" @default.
• W1992514303 type Work @default.
• W1992514303 sameAs 1992514303 @default.
• W1992514303 citedByCount "93" @default.
• W1992514303 countsByYear W19925143032012 @default.
• W1992514303 countsByYear W19925143032013 @default.
• W1992514303 countsByYear W19925143032014 @default.
• W1992514303 countsByYear W19925143032015 @default.
• W1992514303 countsByYear W19925143032016 @default.
• W1992514303 countsByYear W19925143032017 @default.
• W1992514303 countsByYear W19925143032018 @default.
• W1992514303 countsByYear W19925143032019 @default.
• W1992514303 countsByYear W19925143032020 @default.
• W1992514303 countsByYear W19925143032021 @default.
• W1992514303 countsByYear W19925143032022 @default.
• W1992514303 countsByYear W19925143032023 @default.
• W1992514303 crossrefType "journal-article" @default.
• W1992514303 hasAuthorship W1992514303A5000121125 @default.
• W1992514303 hasAuthorship W1992514303A5001557696 @default.
• W1992514303 hasAuthorship W1992514303A5003889511 @default.
• W1992514303 hasAuthorship W1992514303A5006390169 @default.
• W1992514303 hasAuthorship W1992514303A5007634841 @default.
• W1992514303 hasAuthorship W1992514303A5014513676 @default.
• W1992514303 hasAuthorship W1992514303A5020085664 @default.
• W1992514303 hasAuthorship W1992514303A5027819464 @default.
• W1992514303 hasAuthorship W1992514303A5039202604 @default.
• W1992514303 hasAuthorship W1992514303A5042005001 @default.
• W1992514303 hasAuthorship W1992514303A5072289832 @default.
• W1992514303 hasAuthorship W1992514303A5090472542 @default.
• W1992514303 hasBestOaLocation W19925143031 @default.
• W1992514303 hasConcept C121608353 @default.
• W1992514303 hasConcept C126322002 @default.
• W1992514303 hasConcept C143998085 @default.
• W1992514303 hasConcept C2776214593 @default.
• W1992514303 hasConcept C2777704314 @default.
• W1992514303 hasConcept C2908647359 @default.
• W1992514303 hasConcept C535046627 @default.
• W1992514303 hasConcept C60644358 @default.
• W1992514303 hasConcept C71924100 @default.
• W1992514303 hasConcept C86803240 @default.
• W1992514303 hasConcept C99454951 @default.
• W1992514303 hasConceptScore W1992514303C121608353 @default.
• W1992514303 hasConceptScore W1992514303C126322002 @default.
• W1992514303 hasConceptScore W1992514303C143998085 @default.
• W1992514303 hasConceptScore W1992514303C2776214593 @default.
• W1992514303 hasConceptScore W1992514303C2777704314 @default.
• W1992514303 hasConceptScore W1992514303C2908647359 @default.
• W1992514303 hasConceptScore W1992514303C535046627 @default.
• W1992514303 hasConceptScore W1992514303C60644358 @default.
• W1992514303 hasConceptScore W1992514303C71924100 @default.
• W1992514303 hasConceptScore W1992514303C86803240 @default.
• W1992514303 hasConceptScore W1992514303C99454951 @default.
• W1992514303 hasIssue "3-4" @default.
• W1992514303 hasLocation W19925143031 @default.
• W1992514303 hasLocation W19925143032 @default.
• W1992514303 hasLocation W19925143033 @default.
• W1992514303 hasLocation W19925143034 @default.
• W1992514303 hasOpenAccess W1992514303 @default.
• W1992514303 hasPrimaryLocation W19925143031 @default.
• W1992514303 hasRelatedWork W1987413475 @default.
• W1992514303 hasRelatedWork W2008054780 @default.
• W1992514303 hasRelatedWork W2183206980 @default.
• W1992514303 hasRelatedWork W2514733910 @default.
• W1992514303 hasRelatedWork W3127173649 @default.
• W1992514303 hasRelatedWork W3134134177 @default.
• W1992514303 hasRelatedWork W3149563891 @default.
• W1992514303 hasRelatedWork W4366975589 @default.
• W1992514303 hasRelatedWork W4379526598 @default.
• W1992514303 hasRelatedWork W4382117200 @default.
• W1992514303 hasVolume "11" @default.
• W1992514303 isParatext "false" @default.
• W1992514303 isRetracted "false" @default.
• W1992514303 magId "1992514303" @default.

• next